FILE PHOTO: Ozempic is displayed in a pharmacy in Provo

FILE PHOTO: A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File Photo

Sign up for our free The Cheap Investor Newsletter!

Discover new market trends and ideas directly to your inbox.

✅ You're in! Check your inbox soon.

By submitting your email address, you'll receive a free subscription to The Cheap Investor newsletter (Privacy Policy). These newsletters are completely free - and always will be. You will also receive occasional offers about products and services available to you from our affiliates. You can unsubscribe at any time.